PDF (204kB) - Nur für Mitarbeiter des Archivs |
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.1243
Zusammenfassung
BACKGROUND: Nicotine is of therapeutic value in ulcerative colitis, but its administration is connected with adverse events. Nicotine derivatives are currently being tested to maintain the therapeutic effects and minimize adverse events. TC-2403-12 is a (E)-metanicotine hemigalactarate. The aim of this study was to determine the effectiveness of TC-2403-12 in the inhibition of TNF- and ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags